Ritter Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch RTTR and buy or sell other stocks, ETFs, and their options commission-free!About RTTR
Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28.
CEOAndrew J. Ritter, MBA
CEOAndrew J. Ritter, MBA
Employees—
Employees—
HeadquartersLos Angeles, California
HeadquartersLos Angeles, California
Founded2004
Founded2004
Employees—
Employees—
RTTR Key Statistics
Market cap34.24M
Market cap34.24M
Price-Earnings ratio-0.29
Price-Earnings ratio-0.29
Dividend yield—
Dividend yield—
Average volume131.04K
Average volume131.04K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$8.81
52 Week high$8.81
52 Week low$1.61
52 Week low$1.61
Stock Snapshot
Ritter Pharmaceuticals(RTTR) stock is priced at $11.20, giving the company a market capitalization of 34.24M. It carries a P/E multiple of -0.29.
During the trading day, Ritter Pharmaceuticals(RTTR) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 131.04K.
Over the past 52 weeks, Ritter Pharmaceuticals(RTTR) stock has traded between a high of $8.81 and a low of $1.61.
Over the past 52 weeks, Ritter Pharmaceuticals(RTTR) stock has traded between a high of $8.81 and a low of $1.61.
People also own
Based on the portfolios of people who own RTTR. This list is generated using Robinhood data, and it’s not a recommendation.